Grifols SA (GRFS)

22.51
0.04 0.18
NASDAQ : Health Technology
Prev Close 22.55
Open 22.52
Day Low/High 22.36 / 22.60
52 Wk Low/High 19.92 / 25.18
Volume 170.95K
Avg Volume 729.70K
Exchange NASDAQ
Shares Outstanding 261.43M
Market Cap 18.49B
P/E Ratio 44.18
Div & Yield 0.28 (1.26%)

Latest News

Grifols Announces New Agreement With Henry Schein To Distribute Normal Saline Solution In The U.S.

Grifols Announces New Agreement With Henry Schein To Distribute Normal Saline Solution In The U.S.

- The FDA approval received in 2017 allows Grifols to market its Normal Saline solution in 500mL polypropylene bags in the U.S. to mitigate the current shortage of Normal Saline in this market

Grifols HyperRAB® (rabies Immune Globulin [human]) 300 IU/mL Receives FDA Approval To Treat Patients Exposed To Rabies Virus Infection

Grifols HyperRAB® (rabies Immune Globulin [human]) 300 IU/mL Receives FDA Approval To Treat Patients Exposed To Rabies Virus Infection

Innovative new formulation delivers higher concentration of anti-rabies virus antibodies per mL at wound site compared to other rabies immune globulin products on the market

Grifols Misterium® Cleanroom Solutions Expands To Include Revolutionary Decontamination Air And Surface Disinfection Systems For Pharmaceutical Preparation

Grifols Misterium® Cleanroom Solutions Expands To Include Revolutionary Decontamination Air And Surface Disinfection Systems For Pharmaceutical Preparation

Grifols is now exclusive distributor for airinspace® air decontamination and surface disinfection technologies

Hologic Agrees to Sell Blood Screening Business to Grifols for $1.85B

Hologic Agrees to Sell Blood Screening Business to Grifols for $1.85B

Hologic and Grifols have worked together since 1998 building a blood screening business, and now Hologic will sell its share to Grifols.

Grifols Immunohematology Center Laboratory In San Marcos, Texas, Has Expanded Its Testing Capabilities To Include Basic And Advanced Serological And Molecular Testing. (Graphic: Business Wire)

Grifols Immunohematology Center Laboratory In San Marcos, Texas, Has Expanded Its Testing Capabilities To Include Basic And Advanced Serological And Molecular Testing. (Graphic: Business Wire)

Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS), a global healthcare company, has expanded the menu of tests offered at the Grifols Immunohematology Center laboratory to include basic and advanced serological and molecular...

5 Big Dividend Stocks Billionaire John Paulson Loves

5 Big Dividend Stocks Billionaire John Paulson Loves

Here's a closer look at five dividend stocks that Paulson & Co. owned in the most recently reported quarter.

3 Stocks Pulling The Health Services Industry Downward

3 Stocks Pulling The Health Services Industry Downward

TheStreet highlights 3 stocks pushing the drugs industry lower today.

3 Stocks Pushing The Health Services Industry Higher

3 Stocks Pushing The Health Services Industry Higher

TheStreet highlights 3 stocks pushing the drugs industry higher today.

3 Health Services Stocks Driving The Industry Higher

3 Health Services Stocks Driving The Industry Higher

TheStreet highlights 3 stocks pushing the drugs industry higher today.

Weak On High Volume: Grifols (GRFS)

Weak On High Volume: Grifols (GRFS)

Trade-Ideas LLC identified Grifols (GRFS) as a weak on high relative volume candidate

8 Biotech Stocks That Should Be in Your Portfolio Right Now

8 Biotech Stocks That Should Be in Your Portfolio Right Now

Which biotech companies are the best investments for your portfolio? Consider buying any of these eight A+ rated stocks.

3 Stocks Raising The Health Services Industry Higher

3 Stocks Raising The Health Services Industry Higher

TheStreet highlights 3 stocks pushing the drugs industry higher today.

3 Stocks Pushing The Drugs Industry Lower

3 Stocks Pushing The Drugs Industry Lower

TheStreet highlights 3 stocks pushing the Drugs industry lower today.

Grifols (GRFS) Strong On High Relative Volume Today

Grifols (GRFS) Strong On High Relative Volume Today

Trade-Ideas LLC identified Grifols (GRFS) as a strong on high relative volume candidate

Strong On High Relative Volume: Grifols (GRFS)

Strong On High Relative Volume: Grifols (GRFS)

Trade-Ideas LLC identified Grifols (GRFS) as a strong on high relative volume candidate

First Week of GRFS February 2016 Options Trading

First Week of GRFS February 2016 Options Trading

Investors in Grifols SA, Barcelona saw new options become available this week, for the February 2016 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 217 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

3 Stocks Advancing The Drugs Industry

3 Stocks Advancing The Drugs Industry

TheStreet highlights 3 stocks pushing the drugs industry higher today.

3 Stocks Improving Performance Of The Drugs Industry

3 Stocks Improving Performance Of The Drugs Industry

TheStreet highlights 3 stocks pushing the drugs industry higher today.

3 Stocks Driving The Health Care Sector Higher

3 Stocks Driving The Health Care Sector Higher

TheStreet highlights 3 stocks pushing the health care sector higher today.

4 Stocks Spiking on Unusual Volume: Novo Nordisk and More

4 Stocks Spiking on Unusual Volume: Novo Nordisk and More

Unusual volume can be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.

3 Health Services Stocks Nudging The Industry Higher

3 Health Services Stocks Nudging The Industry Higher

TheStreet highlights 3 stocks pushing the health services industry higher today.

3 Stocks Pushing The Health Services Industry Lower

3 Stocks Pushing The Health Services Industry Lower

TheStreet highlights 3 stocks pushing the Health Services industry lower today.

3 Stocks Pushing The Health Care Sector Lower

3 Stocks Pushing The Health Care Sector Lower

TheStreet highlights 3 stocks pushing the Health Care sector lower today.

3 Stocks Raising The Drugs Industry Higher

3 Stocks Raising The Drugs Industry Higher

TheStreet highlights 3 stocks pushing the drugs industry higher today.

3 Stocks Boosting The Drugs Industry Higher

3 Stocks Boosting The Drugs Industry Higher

TheStreet highlights 3 stocks pushing the drugs industry higher today.

3 Stocks Pushing The Health Services Industry Lower

3 Stocks Pushing The Health Services Industry Lower

TheStreet highlights 3 stocks pushing the Health Services industry lower today.

3 Stocks Pushing The Drugs Industry Lower

3 Stocks Pushing The Drugs Industry Lower

TheStreet highlights 3 stocks pushing the Drugs industry lower today.

TheStreet Quant Rating: B (Buy)